INTRODUCTION
Carotid artery stenosis, the narrowing of the lumen of the carotid artery, decreases blood flow to the brain and is known to cause ischemic stroke [1, 2] . For treatment of carotid artery stenosis, medical treatment, carotid endarterectomy (CEA) and carotid stenting can be used [3] . Among these therapies, CEA was reported for the first time in 1954 [4] . In the early 1980s, studies regarding CEA showed negative results such as high post operation morbidity [5, 6] . Since then, several large multicenter trials verified the safety and durability of CEA [7] [8] [9] [10] and CEA is widely accepted as a standard treatment for symptomatic and asymptomatic significant carotid stenosis [11] . There are two main surgical techniques in CEA, conventional carotid endarterectomy (cCEA) and eversion carotid endarterectomy (eCEA). The first includes a standard longitudinal carotid arteriotomy with or without patch angioplasty. The second is done in order of oblique transection, eversion of internal carotid artery (ICA) and reimplantation of the latter into the common carotid artery. eCEA was initially described by De Bakey [12] and later generalized by others [13] [14] [15] .
Although CEA is known to be safe [7] [8] [9] [10] , CEA has intraoperative and postoperative risks. Complications that are directly associated with the surgical procedure are strokes, myocardial infarction, death, restenosis and so on [16] [17] [18] . There are medical complications that are not directly caused by the procedure, such as myocardial infarctions, other cardiovascular disorders, respiratory complications, and transient confusions [19] . Thus, to find a better surgical technique for treatment of carotid artery stenosis is a very important issue; comparative results cCEA and eCEA have been reported in many studies. In Korea, there have been no reports to compare the outcome of the two techniques. Thus, we investigated the results of eCEA compared to cCEA in Yeungnam University Medical Center.
METHODS

Study population
From August 2004 to March 2012, 120 patients underwent CEA by one surgeon in Yeungnam University Medical Center. All of these patients were included this study. Of them, cCEAs were performed in 63 patients and eCEAs were performed in 57 patients. The indication of CEA were symptomatic patients with stenosis over seventy percent according to North American Symptomatic Carotid Endarterectomy Trial (NASCET) criteria and asymptomatic patients were considered when they had a stenosis over eighty percent or over fifty percent if the lesion was ulcerative. The luminal area diameter by CT angiography was used for the assessment of carotid artery stenosis. Symptomatic patients were defined as those who had experienced amaurosis fugax, a transient ischemic attack (TIA), or a stroke in the territory of the ipsilateral carotid artery before entry.
Surgical procedure
Patients had been given at least 1 antiplatelet agent (aspirin, 100 mg daily; cilostazol, 200 mg daily; or clopidogrel, 75 mg daily) for a minimum of 7 days before the operation. CEA was performed under general anesthesia with intraoperative monitoring. Intraoperative monitoring was done by transcranial doppler (TCD) or electroencephalography. Before the clamping of carotid artery, intravenous heparin (5,000 units) was administered to prevent the occurrence of acute thrombosis. When ICA blood flow was reduced over 50% after clamping of ICA on TCD or the bones of the skull blocked the transmission of ultrasound, selective shunt (Pruitt-Inahara carotid shunt with T-port, LeMaitre Vascular Inc., Burlington, MA, USA) was placed. Surgical options comprised conventional and eCEA. cCEA is preferred when shunt is needed or the level of lesion is high. But it is not a definite indication. The type of operation is at the discretion of the operator. Intraoperative data including the frequency of shunt, clamping time and operation time were examined.
Patient assessment
Preoperative and postoperative neurological examinations were investigated by a neurologist. MR imaging (Gyroscan Intera 1.5T, Philips Medical Systems, Best, The Netherlands) was performed in all patients within 1 week after treatment. The protocol included isotropic DWI sequence. MRI images were analyzed by experienced neuroradiologists. Duplex scan (iU22 xMATRIX ultrasound system, Philips Medical Systems, Bothell, USA) was performed on all the patients at 1, 3, 6, and 12 months for the first year and annually thereafter. Restenosis was defined as a reduction over 50% of the lumen and ICA peak systolic velocity over one hundred and twenty-five centimeter per second on Duplex scan. We analyzed the results divided into early (within 30 days after surgery), midterm (from 30 days up to 1 year after surgery) and late (over 1 year after surgery) groupings. Early complications were examined for the frequency of postoperative stroke/TIA, myocardial infarction, cerebral hyperperfusion syndrome, postoperative intracranial hemorrhage, wound complication, cranial nerve palsy, new brain lesions on diffusion-weighted MRI and mortality. Cerebral hyperperfusion syndrome is defined as ipsilateral headache, hypertension, seizures, and focal neurological deficits. Midterm and late complications included restenosis, stroke and mortality.
Statistical analysis
Statistical analysis was performed using PASW Statistics ver. 18.0 (SPSS Inc., Chicago, IL, USA). Continuous data are reported as mean ± standard deviation. Nominal data were reported as number of subjects and percentage of individuals affected. Univariate analyses were performed to compare cCEA with eCEA in aspect of complications. For univariate analysis we used chi-square test, Fisher exact test and Student t-test. A P-value < 0.05 was considered to be statistically significant.
RESULTS
Demographic and clinical characteristics of total patients are presented in Table 1 . A total of 120 patients were included this study. Mean age of the patients was 65.9 ± 7.1 years in cCEA group and 66.8 ± 7.7 years in eCEA group (P = 0.523). The percentage of males was 85.7% in cCEA group and 89.5% in eCEA group (P = 0.534). Mean diameter of stenosis was 78.5 ± 13.3 in cCEA group and 78.9 ± 11.4 in eCEA group (P = 0.864) in accordance with NASCET criteria. The common comorbidities were hypertension and smoking followed by diabetes, hyperlipidemia and ischemic heart disease. Table 2 shows intraoperative data. Shunts were used in 36 cases for the prevention of ischemic events. The number of patients using shunts was 25 of 63 (39.7%) in cCEA group, 11 of 57 (19.3%) in eCEA group. Carotid shunt frequency was higher in the cCEA group (P = 0.015). There were no statistical differences in clamping time (21.3 ± 9.7 vs. 24.0 ± 8.7, P = 0.117) and operating time (143.9 ± 36.2 vs. 139.9 ± 30.8) between cCEA and eCEA.
We examined the early, midterm and late postoperative complications. Table 3 shows the early complications within 30 days after CEA. There were 7 cases of postoperative stroke/ TIA, 4 of 63 (6.3%) in cCEA group and 3 of 57 (5.3%) in eCEA group (P = 0.800). There was no postoperative myocardiac infarction and mortality in both groups. Only 1 case (1.6%) of cerebral hyperperfusion syndrome was developed in cCEA group. Intracranial hemorrhage occurred in 2 of 63 (3.2%) in cCEA and 1 of 57 (1.8%) in eCEA (P = 0.619). There was no significant difference in wound complication between cCEA and eCEA (3.2% vs. 1.8%, P = 0.619). The incidence of cranial nerve palsy was similar in the cCEA group compared to eCEA group (4.8% vs. 1.8%, P = 0.359). All of these events were treated conservatively without any complication. There were no statistical differences in the early complications with the exception of a significantly higher risk for new brain lesions in the cCEA group. The incidence for new brain lesions was higher in cCEA group compared to eCEA group (34.9% vs. 14.0%, P = 0.008). There were no statistical differences in midterm complication between cCEA and eCEA group. Restenosis and stroke occurred in 1 of 63 (1.6%) in cCEA group and 1 of 57 (1.8%) in eCEA group (P = 0.943). They were treated without any sequelae. And there were no deaths during the period (Table 4) .
Mean follow-up duration was 29.4 ± 23.5 months. Over 1 year after CEA, there were 2 cases of restenosis (3.2%) and 1 case of stroke (1.6%) in cCEA. On the other hand, there were only 1 case of restenosis (1.8%) and no stroke in eCEA. Although there was no statistical significance, the frequency of late complications was higher in the cCEA group compared to eCEA group (Table 5) .
DISCUSSION
In this study, CEA was performed with acceptable periprocedural complication rates. There are no fatal complications, such as ipsilateral disabling stroke, myocardial infarction and mortality. And cCEA has a higher risk for new brain lesions within 30 days after cCEA. There were no statistical differences in midterm complication between cCEA and eCEA. In late complication, although there was no statistical significance, the frequency of restenosis and stroke was higher in the cCEA compared to eCEA.
eCEA is reported to have advantages within the procedure itself. Even though clamping times were similar in both cCEA and eCEA groups in our data, clamping times during eCEA was shorter compared with patch standard procedures (P = 0.02) in the EVERST trial [20] . The authors suggested that eCEA is a safe and rapid procedure. eCEA is associated with more possibility for having short operation time compared to cCEA [21] . Synthetic material is not required during eCEA and there are no problems related with synthetic materials. On the other hand, cCEA also has its own advantages. Longitudinal arteriotomy that is performed during cCEA can extend from the common carotid artery to the ICA. So, it makes for easy handling of the atherosclerotic lesions at high levels [22] .
There is controversy about the surgical outcomes of these two surgical methods. The EVERST trial reported the potential superiority of eCEA. This trial was a multicenter randomized study and the first trial performed in a large population to assess the role of eCEA for treating patients with carotid artery stenosis. Preliminary results were published in 1998 [20] . Six hundred seventy-five cCEAs and 678 eCEAs were performed. The incidence of any stroke, TIA, cranial nerve injury, wound hematoma, myocardial infarction and major stroke death at 30 days after CEA was not statistically different between the two groups. It is in line with our study. New brain lesion on diffuse-weighted MRI was not investigated in the EVEREST trial. In 1999, late results of the EVEREST trial were released [23] . After 30 days of CEA, no significant differences in the neurologic outcomes, myocardial infarction and death were found between the two study groups. Restenosis occurred in 37 of 675 (5.52%) in cCEA and 19 of 678 (2.8%) in eCEA. In our study, restenosis during mid and late term developed in 3 of 63 (4.7%) in cCEA and 2 of 57 (3.5%) in eCEA. Although our data showed no statistical differences in restenosis rates between the two groups, late results of the EVEREST trial reported high frequency of restenosis in cCEA group compared to eCEA group. Meta-analysis by Antonopoulos et al. [24] also presented the potential superiority of eCEA. In this analysis, a total 21 studies, which consisted of 7 randomized and 14 nonrandomized studies, were analyzed. eCEA showed superiority regarding perioperative stroke, perioperative death and stroke related death in short-term outcomes, but no significant difference was observed in the risk for these outcomes between cCEA and eCEA in our study. New brain lesion on diffuse-weighted MRI was not included in the outcomes. Concerning long-term outcomes, eCEA was associated with a statistically significant reduction in coronary artery occlusion and mortality. The endarterectomy subgroups analysis from the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE-1) trial [25] suggested that the two surgical methods have its own advantages. Demirel et al. [25] analyzed 563 patients underwent cCEA or eCEA from SPACE-1 study. Ipsilateral stroke and death within 30 days after surgery occurred more frequently in eCEA group compared to cCEA group. In our study concerning early complication, there was no statistical significance in the incidence of stroke/TIA, cCEA had a high risk for new brain lesion on diffuse-weighted MRI. cCEA was associated with a significantly higher risk of ipsilateral stroke beyond the 30-day perioperative period. There are some differences in the frequency and type of complications probably originating from regional differences, study method, patient characteristics, surgical technique and so on. But, in most studies including our research, it seems obvious that eCEA is not inferior to cCEA.
In conclusion, our data showed that eCEA was an acceptable procedure and had some advantage compared to cCEA in aspect of the early and late complication.
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